Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California Baby Will Transition Products To New 100% Plant-Based Preservative

Executive Summary

The Los Angeles-based natural product trailblazer says it will be positioned to use 100% bio-based claims – and USDA’s corresponding certification logo – thanks to its new plant-based preservative system. The innovation should serve as a signal to the wider industry and FDA that 100% plant-based skin-care products are possible, the company’s founder suggests.

Advertisement

Related Content

FDA Analysis Of Non-Traditionally Preserved Cosmetics Indicates Likely Contamination Source
GC3 Preservatives Challenge: Winning Innovations To Be Decided By Month’s End
'Natural' Plaintiffs Pivot From Mainstream Money To Category Pioneers
Lush Scientist On Firm’s Evolving (And Expensive) Self-Preserving Platform
New Nonprofit NAC Seeks ‘Natural’ Legislation, Data-Sharing Forum
FDA Seeks Comment On 'Natural' Food Labeling; Cosmetics Not Mentioned

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS121722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel